TREATING THE UNTREATABLE. Children with Dravet and Lennox-Gastaut syndrome typically experience multiple types of seizures, as well as learning problems and intellectual disabilities that often prevent them from ever living "normal" lives.
There are already six drugs on the market that treat Lennox-Gastaut. But there aren't any approved medications for Dravet syndrome. That means Epidiolox could be patients' only hope at treating their debilitating illness. Even more, doctors could choose to prescribe the medication "off-label" (for conditions not officially approved), expanding the number of patients it could help.